ロード中...
The role of Asprosin in patients with dilated cardiomyopathy
BACKGROUND: Asprosin is a novel fasting glucogenic adipokine discovered in 2016. Asprosin induces rapid glucose releases from the liver. However, its molecular mechanisms and function are still unclear. Adaptation of energy substrates from fatty acid to glucose is recently considered a novel therape...
保存先:
| 出版年: | BMC Cardiovasc Disord |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7487662/ https://ncbi.nlm.nih.gov/pubmed/32894050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-020-01680-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|